Medscape (11/2, Warren, Subscription Publication) reports, “Patients age 65 and older who receive thyroid hormone therapy and experience low thyrotropin are at increased risk for dementia and other cognitive problems, according to” a study. Investigators “also found that women were more likely to have low levels of thyrotropin…than men and were more likely to be overtreated.” The findings were published in JAMA Internal Medicine.
Related Links:
— Medscape (requires login and subscription)